Lateral Extra-Articular Tenodesis for ACL Reconstruction Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to determine whether the addition of Lateral Extra-Articular Tenodesis (LET) influences postoperative lower-extremity LM recovery following bone-patellar tendon-bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR). We hypothesize that patients undergoing ACLR BTB with LET will demonstrate greater loss of operative-leg LM at 9 months postoperatively compared with patients undergoing isolated ACLR BTB.
Who Is on the Research Team?
Amit Moma, MD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults up to age 60 with a recent ACL injury (within 6 weeks) who are scheduled for their first bone-patellar tendon-bone ACL reconstruction, with or without an added LET procedure. People with nerve/muscle disorders, previous ACL surgeries, injuries in the other knee, or those pregnant/nursing cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery and Initial Recovery
Participants undergo Anterior Cruciate Ligament Reconstruction (ACLR) with or without Lateral Extra-Articular Tenodesis (LET)
Postoperative Rehabilitation
Participants engage in rehabilitation to recover lower-extremity lean mass following surgery
Follow-up
Participants are monitored for lower-extremity lean mass recovery and safety post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Bone-patellar Tendon-bone (BTB) Anterior Cruciate Ligament Reconstruction
- Lateral Extra-Articular Tenodesis (LET)
Trial Overview
The study compares two surgical approaches: standard bone-patellar tendon-bone (BTB) ACL reconstruction versus BTB plus Lateral Extra-Articular Tenodesis (LET), to see which helps leg muscle mass recover better after surgery.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants undergoing Anterior Cruciate Ligament Reconstruction (ACLR) will receive both Bone-patellar Tendon-bone (BTB) and Lateral Extra-Articular Tenodesis (LET)
Participants undergoing Anterior Cruciate Ligament Reconstruction (ACLR) will receive Bone-patellar Tendon-bone (BTB)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.